H.R. 6620 · 116th Congress
To authorize grants to address substance use during COVID-19.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
KusterSponsor
This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies.
What it does: CRS summary · Introduced in House · Apr 24, 2020
This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To authorize grants to address substance use during COVID-19.
Latest action (Apr 24, 2020): Referred to the House Committee on Energy and Commerce.
Policy area: Health · Origin: House · Introduced: Apr 24, 2020
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.